Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cencora's cash flow for dividends for the
three
months ended in Jun. 2026 was MXN-1,988 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-8,403 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
Cencora's quarterly payment of dividends
declined
from Dec. 2025 (MXN-2,316 Mil) to Mar. 2026 (MXN-1,969 Mil) but then
increased
from Mar. 2026 (MXN-1,969 Mil) to Jun. 2026 (MXN-1,988 Mil).
Cencora's annual payment of dividends
increased
from Sep. 2023 (MXN-7,290 Mil) to Sep. 2024 (MXN-7,365 Mil) and
increased
from Sep. 2024 (MXN-7,365 Mil) to Sep. 2025 (MXN-8,589 Mil).
The historical data trend for Cencora's Cash Flow for Dividends can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-8,403 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow for Dividends of MXN-8,403 Mil mean?
Cencora (MEX:COR) has a Cash Flow for Dividends of MXN-8,403 Mil as of Jun. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cencora and its competitors.
Is Cencora's Cash Flow for Dividends too high?
Cencora's current Cash Flow for Dividends is MXN-8,403 Mil. Overall, Cencora has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Cash Flow for Dividends compare to CAH and MCK?
Cencora's Cash Flow for Dividends of MXN-8,403 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Distribution company?
A good Cash Flow for Dividends depends on the Medical Distribution industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Cencora and its competitors. Cencora's current Cash Flow for Dividends is MXN-8,403 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (MEX:COR) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN4,582.83, compared to a current price of MXN5,350.75 — trading 16.8% above its estimated fair value. The current Cash Flow for Dividends is MXN-8,403 Mil. Cencora's overall GF Score™ is 53/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Cencora (MEX:COR), the current Cash Flow for Dividends is MXN-8,403 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (MEX:COR) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be overvalued.
The current stock price of MXN5,350.75 is trading 16.8% above its estimated GF Value™ of MXN4,582.83.
GuruFocus considers Cencora to be Modestly Overvalued.
Key valuation signals for MEX:COR:
Cash Flow for Dividends: MXN-8,403 Mil
GF Value™: MXN4,582.83 vs. price of MXN5,350.75 (16.8% above fair value)
No single metric tells the full story. See the MEX:COR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
53GF Score
Get the complete analysis for MEX:COR
Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:COR has been successfully added to your 
